Valuation: PharmaEssentia Corporation

Market Cap 622B 19.43B 16.78B 15.77B 14.34B 26.96B 1,858B 27.41B 185B 72.24B 930B 72.95B 71.36B 3,092B P/E 2026 *
60.4x
P/E 2027 * 38.6x
Enterprise Value 595B 18.6B 16.06B 15.1B 13.73B 25.81B 1,779B 26.24B 177B 69.16B 891B 69.83B 68.32B 2,960B EV / Sales 2026 *
21.4x
EV / Sales 2027 * 15.8x
Free-Float
68.31%
Yield 2026 *
0.06%
Yield 2027 * 0.1%
1 day+3.81%
1 week+16.28%
Current month+41.51%
1 month+20.00%
3 months+112.78%
6 months+129.51%
Current year+254.02%
1 week 1,190
Extreme 1190
1,550
1 month 1,015
Extreme 1015
1,550
Current year 423.7
Extreme 423.699083
1,550
1 year 397.24
Extreme 397.238043
1,550
3 years 222.58
Extreme 222.58328
1,550
5 years 56.05
Extreme 56.051993
1,550
10 years 43.54
Extreme 43.541837
1,550
Manager TitleAgeSince
Chief Executive Officer - 2016-12-31
Director of Finance/CFO - 2015-10-13
President - 2015-06-24
Director TitleAgeSince
Director/Board Member - 2000-05-08
Chairman - 2012-09-23
Director/Board Member - 2015-05-28
Change 5-day change 1-year change 3-year change Capi.($)
+3.81%+16.28%+270.78%+488.06% 18.64B
-1.90%+11.59%+62.29%+102.60% 71.56B
-3.21%-4.32%+31.19%+59.75% 54.43B
-2.72%-6.17%-3.71%+451.61% 27.59B
-1.27%+9.09%+46.56%+4.13% 23.91B
-0.57%-2.02%-18.56%-14.58% 23.14B
+0.10%+1.40%+38.98%-20.04% 18.65B
-0.95%+2.46%+24.40%+574.22% 16.01B
+0.24%-6.42%+31.53%+135.24% 12.54B
+0.13%-0.45%+36.73%+192.76% 11.72B
Average -0.64%+2.61%+52.02%+197.37% 27.82B
Weighted average by Cap. -1.32%+1.62%+49.35%+160.63%

Financials

2026 *2027 *
Net sales 27.76B 868M 749M 704M 640M 1.2B 82.96B 1.22B 8.25B 3.23B 41.54B 3.26B 3.19B 138B 37.08B 1.16B 1B 941M 855M 1.61B 111B 1.63B 11.02B 4.31B 55.49B 4.35B 4.26B 184B
Net income 10.49B 328M 283M 266M 242M 455M 31.35B 462M 3.12B 1.22B 15.7B 1.23B 1.2B 52.17B 16.25B 508M 439M 412M 375M 705M 48.57B 716M 4.83B 1.89B 24.32B 1.91B 1.87B 80.82B
Net Debt -26.52B -829M -716M -673M -612M -1.15B -79.27B -1.17B -7.88B -3.08B -39.7B -3.11B -3.04B -132B -34.73B -1.09B -937M -881M -801M -1.51B -104B -1.53B -10.32B -4.04B -51.97B -4.08B -3.99B -173B
Logo PharmaEssentia Corporation
PharmaEssentia Corp is a Taiwan-based company mainly engaged in the research, development, production and sale of new drugs. The Company is engaged in the research and development of new drugs, which are used for treatment of hematology, such as meloproliferative neoplasms (MPN), neutropenia, anemia; infectious disease, such as hepatitis C and hepatitis B; dermatology, such as psoriasis, and neurology, such as multiple sclerosis, among others. The Company’s products include KX01, P1101, Polycythemia Vera (PV), PEG-GCSF, PEG-EPO and others. The Company distributes its products within domestic market and to overseas markets.
Employees
131
Date Price Change Volume
26-08-13 NT$1,500.00 +3.81% 4,008,330
26-08-13 NT$1,445.00 +0.35% 3,404,968
26-08-12 NT$1,440.00 -1.37% 6,003,196
26-08-11 NT$1,460.00 +9.77% 5,613,829
26-08-10 NT$1,330.00 +7.26% 4,265,061
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
1,445.00TWD
Average target price
1,216.34TWD
Spread / Average Target
-15.82%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 6446 Stock